Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion type Assertion NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_head.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion description "[Firstly, 22 transcripts are identified to have new roles in modulating the DAS28 score; secondly, there are 6 transcripts that could be alternative targets to TNF-? blocker therapies, including CD86--a component of the signaling axis targeted by Abatacept (CTLA4-Ig), and finally, 59 transcripts that are predicted to modulate the count of tender or swollen joints but not sufficiently enough to have a significant impact on DAS28.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_provenance.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion evidence source_evidence_literature NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_provenance.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion SIO_000772 21423713 NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_provenance.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion wasDerivedFrom befree-20140225 NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_provenance.
- NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_assertion wasGeneratedBy ECO_0000203 NP742698.RAHMjvVfzZOaBbxGcihUBexKQn1RbsXlQ2T7FDyWjRosc130_provenance.